It simultaneously synergizes with IL-17A and IL-17F to induce antimicrobial peptide expression in epithelial cells and mediate an early mucosal defense response to pneumonia-causing microorganisms in a mouse model [47,48]. Here, IL17A is linked to susceptibility to pneumonia measurement.